[1] Prusiner SB: Prions. Proceedings of the national academy of sciences of the United States of America, 1998; 95, 13363-83.
[2] Collins S, Boyd A, Fletcher A, et al. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. J Clin Neurosci, 2000; 7, 203−8. doi:  10.1054/jocn.1999.0193
[3] McGuire LI, Peden AH, Orru CD, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol, 2012; 72, 278−85. doi:  10.1002/ana.23589
[4] Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med, 2011; 17, 175−78. doi:  10.1038/nm.2294
[5] Orru CD, Hughson AG, Groveman BR, et al. Factors that improve RT-QuIC detection of prion seeding activity. Viruses, 2016; 8.
[6] Orru CD, Groveman BR, Hughson AG, et al. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. mBio, 2015; 6, e02451–14.
[7] Cramm M, Schmitz M, Karch A, et al. Characteristic CSF prion seeding efficiency in humans with prion diseases. Molecular neurobiology, 2015; 51, 396−405. doi:  10.1007/s12035-014-8709-6
[8] Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and characterisation. British Medi Bull, 2003; 66, 213−39. doi:  10.1093/bmb/66.1.213
[9] Shi Q, Zhou W, Chen C, et al. Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016. Prion, 2016; 10, 484−91. doi:  10.1080/19336896.2016.1229731
[10] Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain, 2010; 133, 3043−57. doi:  10.1093/brain/awq216